Boston Scientific (BSX) Other Non Operating Income (2009 - 2026)

Boston Scientific has disclosed Other Non Operating Income across 18 years of filings, most recently posting -$118.0 million for Q2 2026.

• In Q2 2026, Other Non Operating Income fell 155.4% year-over-year to -$118.0 million; the TTM figure through Jun 2026 stood at -$461.0 million (down 694.83% YoY), while the FY2025 annual figure was -$228.0 million, up 28.97% from the prior year.
• Other Non Operating Income came in at -$118.0 million for Q2 2026 at Boston Scientific, down from $151.0 million in the prior quarter.
• In the past five years, Other Non Operating Income ranged from a high of $213.0 million in Q2 2025 to a low of -$412.0 million in Q4 2022.
• Average Other Non Operating Income over 5 years is -$86.3 million, with a median of -$66.0 million recorded in 2024.
• Year-over-year, Other Non Operating Income slumped 1684.62% in 2022 and surged 313.0% in 2025.
• Over 5 years, Other Non Operating Income stood at -$412.0 million in 2022, then surged by 32.04% to -$280.0 million in 2023, then jumped by 67.86% to -$90.0 million in 2024, then sank by 326.67% to -$384.0 million in 2025, then soared by 69.27% to -$118.0 million in 2026.
• Per Business Quant data, the three most recent Other Non Operating Income figures were -$118.0 million in Q2 2026, $151.0 million in Q1 2026, and -$384.0 million in Q4 2025.